Physician profile
David Powers
NPI 1730169459
$89,892.67
in general payments reported to CMS, 2019-2025
16 companies · $9,672 in 2025
The $9,672 reported for 2025 was more than what 97% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $5,857 · 2021: $5,034 · 2022: $12K · 2023: $10,000 · 2024: $24K · 2025: $9,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Travel and Lodging: $11K · Food and Beverage: $2,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,654.26 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,550.00 |
| Travel and Lodging | $10,551.52 |
| Food and Beverage | $2,767.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $50,622.80 | 2019-2025 | |
| Medical Device Business Services, INC. | $20,756.77 | 2019-2024 | Matrixcombo, Trumatch |
| Stryker Corporation | $10,082.50 | 2019-2020 | |
| Kls-Martin L.P. | $5,385.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,250.00 | 2025 | |
| Depuy Synthes Sales INC. | $1,098.23 | 2019-2025 | Trumatch, Matrixmandible, Matrixorthognathic |
| Axogen | $141.86 | 2020 | |
| Longeviti Neuro Solutions INC | $134.51 | 2023 | |
| Tepha INC | $111.65 | 2019 | |
| Abbott Laboratories | $72.06 | 2022-2024 | Ensite |
| Abbvie INC. | $65.76 | 2025 | |
| Tela Bio, INC. | $51.31 | 2021 | |
| Acera Surgical, INC. | $50.00 | 2021 | |
| Synthes USA Products LLC | $34.09 | 2021 | |
| Polarityte, INC. | $18.25 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $17.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.